Form 4 Filing for Pfizer Inc. - Insider Transaction

Cyrus Taraporevala, a director at Pfizer Inc. (PFE), reported a transaction on April 23, 2026. The transaction involved the acquisition of 7,686.539 phantom stock units, with each unit valued at $26.67. These units are part of a deferred compensation plan for non-employee directors and represent a right to receive cash or common stock upon retirement. Following this transaction, Mr. Taraporevala holds a total of 34,826.086 phantom stock units. The underlying security for these units is Pfizer's common stock. This filing is classified as an Officer/Director change due to the nature of the transaction and the reporting person's role.